IQV - IQVIA HOLDINGS INC.

173.96
-0.310   -0.178%

Share volume: 1,568,010
Last Updated: 03-03-2026
Business Services/Services – Research, Development, Testing Labs: -0.04%

PREVIOUS CLOSE
CHG
CHG%
$174.27
-0.31
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
48%
Profitability 31%
Dept financing 50%
Liquidity 13%
Performance 72%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-2.71%
1 Month
-14.11%
3 Months
-22.66%
6 Months
-5.50%
1 Year
-5.24%
2 Year
-30.85%
Key data
Stock price
$173.96
P/E Ratio 
28.23
DAY RANGE
$168.53 - $174.83
EPS 
$7.91
52 WEEK RANGE
$134.64 - $247.04
52 WEEK CHANGE
-$6.40
MARKET CAP 
38.387 B
YIELD 
N/A
SHARES OUTSTANDING 
169.700 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.63
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$3,025,292
AVERAGE 30 VOLUME 
$3,368,015
Company detail
CEO: Ari Bousbib
Region: US
Website: iqvia.com
Employees: 86,000
IPO year: 2013
Issue type: Common Stock
Market: NYSE
Industry: Business Services/Services – Research, Development, Testing Labs
Sector: Services

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and Asia-Pacific. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services. The Research & Development Solutions segment provides project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services.

Recent news